Cargando…
S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703
| Autores principales: | , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428395/ http://dx.doi.org/10.1097/01.HS9.0000967380.08838.b7 |
| _version_ | 1785090458821591040 |
|---|---|
| author | Wieduwilt, Matthew Yin, Jun Kour, Oudom Teske, Rebecca Stock, Wendy Byrd, Ken Doucette, Kimberly Mangan, James Masters, Gregory Mims, Alice Jamieson, Katarzyna Dinner, Shira Bseiso, Ali Uy, Geoffrey Erba, Harry Litzow, Mark Stone, Richard |
| author_facet | Wieduwilt, Matthew Yin, Jun Kour, Oudom Teske, Rebecca Stock, Wendy Byrd, Ken Doucette, Kimberly Mangan, James Masters, Gregory Mims, Alice Jamieson, Katarzyna Dinner, Shira Bseiso, Ali Uy, Geoffrey Erba, Harry Litzow, Mark Stone, Richard |
| author_sort | Wieduwilt, Matthew |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10428395 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-104283952023-08-17 S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 Wieduwilt, Matthew Yin, Jun Kour, Oudom Teske, Rebecca Stock, Wendy Byrd, Ken Doucette, Kimberly Mangan, James Masters, Gregory Mims, Alice Jamieson, Katarzyna Dinner, Shira Bseiso, Ali Uy, Geoffrey Erba, Harry Litzow, Mark Stone, Richard Hemasphere Oral Sessions Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428395/ http://dx.doi.org/10.1097/01.HS9.0000967380.08838.b7 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Oral Sessions Wieduwilt, Matthew Yin, Jun Kour, Oudom Teske, Rebecca Stock, Wendy Byrd, Ken Doucette, Kimberly Mangan, James Masters, Gregory Mims, Alice Jamieson, Katarzyna Dinner, Shira Bseiso, Ali Uy, Geoffrey Erba, Harry Litzow, Mark Stone, Richard S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title | S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title_full | S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title_fullStr | S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title_full_unstemmed | S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title_short | S117: CHEMOTHERAPY-FREE TREATMENT WITH INOTUZUMAB OZOGAMICIN AND BLINATUMOMAB FOR OLDER ADULTS WITH NEWLY-DIAGNOSED, PH-NEGATIVE, CD22-POSITIVE, B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: ALLIANCE A041703 |
| title_sort | s117: chemotherapy-free treatment with inotuzumab ozogamicin and blinatumomab for older adults with newly-diagnosed, ph-negative, cd22-positive, b-cell acute lymphoblastic leukemia: alliance a041703 |
| topic | Oral Sessions |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428395/ http://dx.doi.org/10.1097/01.HS9.0000967380.08838.b7 |
| work_keys_str_mv | AT wieduwiltmatthew s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT yinjun s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT kouroudom s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT teskerebecca s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT stockwendy s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT byrdken s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT doucettekimberly s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT manganjames s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT mastersgregory s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT mimsalice s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT jamiesonkatarzyna s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT dinnershira s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT bseisoali s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT uygeoffrey s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT erbaharry s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT litzowmark s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 AT stonerichard s117chemotherapyfreetreatmentwithinotuzumabozogamicinandblinatumomabforolderadultswithnewlydiagnosedphnegativecd22positivebcellacutelymphoblasticleukemiaalliancea041703 |